Novo Nordisk Goodwill and Intangible Assets 2010-2024 | NVO

Novo Nordisk goodwill and intangible assets for the quarter ending September 30, 2024 were $8.032B, a 1.28% decline year-over-year.

  • Novo Nordisk goodwill and intangible assets for 2023 were $8.771B, a 20.47% increase from 2022.
  • Novo Nordisk goodwill and intangible assets for 2022 were $7.281B, a 6% increase from 2021.
  • Novo Nordisk goodwill and intangible assets for 2021 were $6.869B, a 117.04% increase from 2020.

Novo Nordisk Goodwill and Intangible Assets 2010-2024 | NVO

  • Novo Nordisk goodwill and intangible assets for 2023 were $8.771B, a 20.47% increase from 2022.
  • Novo Nordisk goodwill and intangible assets for 2022 were $7.281B, a 6% increase from 2021.
  • Novo Nordisk goodwill and intangible assets for 2021 were $6.869B, a 117.04% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B